Related Experiment Video
Updated: Feb 27, 2026

08:44
Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
Published on: October 17, 2025
746
Tuberous sclerosis complex: Recent advances in manifestations and therapy
Mari Wataya-Kaneda1, Motohide Uemura2, Kazutoshi Fujita2
1Department of Dermatology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Summary
Tuberous sclerosis complex (TSC) is a genetic disorder. Recent advances include gene discovery (TSC1/TSC2), understanding the mTOR pathway, and new diagnostic/treatment strategies like genetic testing and mTOR inhibitors.
Area of Science:
- Genetics and Molecular Biology
- Oncology
- Neurology
Background:
- Tuberous sclerosis complex (TSC) is an autosomal dominant disorder affecting multiple organs.
- Genetic mutations in TSC1 and TSC2 genes disrupt the hamartin-tuberin complex.
- This disruption leads to constitutive activation of the mTORC1 pathway, driving disease manifestations.
Purpose of the Study:
- To review recent advancements in understanding TSC.
- To summarize key manifestations and therapeutic strategies for TSC.
- To highlight evolving diagnostic criteria and treatment approaches.
Main Methods:
- Review of recent scientific literature on Tuberous Sclerosis Complex.
- Analysis of genetic discoveries and their functional implications.
- Examination of current diagnostic and therapeutic modalities.
Main Results:
- Discovery of TSC1 and TSC2 genes and elucidation of their role in the mTOR pathway.
- Development of genetic testing for TSC diagnosis.
- Emergence of mTORC1 inhibitors as a treatment option.
- Increased recognition of non-neurological manifestations like renal and pulmonary issues.
Conclusions:
- Significant progress has been made in TSC research, diagnostics, and therapeutics.
- A multidisciplinary "cross-sectional medical examination system" is crucial for TSC management.
- Ongoing research continues to refine our understanding of TSC manifestations and treatments.
Related Concept Videos
Modeling in Therapy
606
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
606
Autism Spectrum Disorder
1.4K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.4K
Pulmonary Tuberculosis IV
575
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
575
Cystic Fibrosis: Management
588
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
588
Pulmonary Tuberculosis V
688
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
688
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K

